⌕
Ideaya Biosciences · IDYA · Nasdaq
Tenet 57 · Mixed
Compare
$30.36−4.62%At closeTenet 57 · Mixed
$30.36−1.47 (−4.62%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Ideaya Biosciences (IDYA) Institutional Ownership

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice

5 figures withheld by our checks. Each blank figure names its reason.

13F fund flowQuarter ended Jun 30, 2026. Withheld: many filers have already reported a later quarter, so their changes in this quarter are not on file and the counts of new, added, trimmed and closed positions are not shown. These positions are 140 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
SHARES HELD BY 13F FILERS
withheld
withheld by our checks · 288 filers, Jun 30, 2026
# 13F FUNDS
288
13F VALUE
$3.8B
102.9M shares
Withheld: the 13F filers report more shares than the company has outstanding, which happens when shared or lent shares are counted twice. The filer count, shares and value are as filed.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Oct 6, 2026Hata Yujiro SPresident and CEOAcquired · Option exercise26,338$4.31↗
Oct 6, 2026Hata Yujiro SPresident and CEODisposed · Open-market sale25,538$37.39↗
Oct 6, 2026Hata Yujiro SPresident and CEODisposed · Open-market sale800$38.26↗
Oct 6, 2026Hata Yujiro SPresident and CEODisposed · Option exercise26,338Stock Option (right to buy)—↗
Jul 7, 2026Ruiz Briseno AndresChief Accounting OfficerAcquired · Option exercise9,550$12.86↗
Jul 7, 2026Ruiz Briseno AndresChief Accounting OfficerDisposed · Open-market sale9,550$40.01↗
Jul 7, 2026Ruiz Briseno AndresChief Accounting OfficerDisposed · Option exercise9,550Stock Option (Right to Buy)—↗
Jun 16, 2026YARNO WENDY LdirectorAcquired · Grant / award20,000Stock Option (right to buy)—↗
Jun 16, 2026Stein JeffreydirectorAcquired · Grant / award20,000Stock Option (right to buy)—↗
Jun 16, 2026ROSEN TERRY JdirectorAcquired · Grant / award20,000Stock Option (right to buy)—↗
Jun 16, 2026Morrison Scott WdirectorAcquired · Grant / award20,000Stock Option (right to buy)—↗
Jun 16, 2026MACKEY CATHERINE JdirectorAcquired · Grant / award20,000Stock Option (right to buy)—↗
Jun 16, 2026Hampton Malcolm GarretdirectorAcquired · Grant / award20,000Stock Option (right to buy)—↗
Mar 2, 2026Stein JeffreydirectorAcquired · Open-market buy50,000$32.96↗
Jan 30, 2026Bleharski JoshuaChief Financial OfficerAcquired · Grant / award170,000Stock Option (right to buy)—↗
Jan 30, 2026WHITE MICHAEL ANTHONYChief Scientific OfficerAcquired · Grant / award190,000Stock Option (right to buy)—↗
Jan 30, 2026Beaupre DarrinChief Medical OfficerAcquired · Grant / award175,000Stock Option (right to buy)—↗
Jan 30, 2026DORMAN STUARTChief Commercial OfficerAcquired · Grant / award155,000Stock Option (right to buy)—↗
Jan 30, 2026Hata Yujiro SPresident and CEOAcquired · Grant / award600,000Stock Option (right to buy)—↗
Jan 30, 2026Snyder Douglas B.SVP, General CounselAcquired · Grant / award130,000Stock Option (right to buy)—↗

* Holdings as reported for Jun 30, 2026, 140 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How many 13F filers hold Ideaya Biosciences?

Ideaya Biosciences was held by 288 13F filers as of Jun 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.